Pay in 4 interest-free payments of $36.25 Learn more
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8
53-bis(2-carboxyethyl)-41-(carboxymethyl)-47-(3-guanidinopropyl)-32-(4-hydroxybenzyl)-38-(hydroxymethyl)-11-isobutyl-8
induces autophagy through inhibition of the MEK/ERK pathway
CCT 007093
Tauroursodeoxycholate (TUDCA) inhibits neointimal hyperplasia by suppression of ERK via PKCα-mediated MKP-1 induction
Chemical Name: N-(5-{[5-(4-acetylpiperazine-1-carbonyl)-4-methoxy-2-methylphenyl]sulfanyl}-1
Rapastinel Trifluoroacetate 10020 53-bis(2-carboxyethyl)-41-(carboxymethyl)-47-(3-guanidinopropyl)-32-(4-hydroxybenzyl)-38-(hydroxymethyl)-11-isobutyl-8Rapastinel Trifluoroacetate (GLYX 13 Trifluoroacetate) is an NMDA receptor modulator with glycine site partial agonist properties. Rapastinel Trifluoroacetate has the potential for major depressive disorder treatment. Product information CAS Number: 1435786 04 1 Molecular Weight: 527. 49 Formula: C20H32F3N5O8 Synonym: GLYX 13 Trifluoroacetate Chemical Name: (2S,3R) 2 {[(2S) 1 [(2S) 1 [(2S,3R) 2 amino 3 hydroxybutanoyl]pyrrolidine 2 carbonyl]pyrrolidin